Kenneth Headen
Psychiatry · Greensboro, NCNPI 1366654329
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,651 of the $9,473 with a category attached, or 70.2%. 21 manufacturers reported payments, led by AbbVie at 36.8% of the total. Reporting peaked in 2019 at $4,664 and has fallen 93.7% since, to $295 in 2023. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 382 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$949
- Sunovion Pharmaceuticals Inc.$944
- Johnson & Johnson$710
- Neurocrine Biosciences, Inc.$651
- Lundbeck LLC$510
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$2,60027%
- Food & beverage$6,65170%
- Education$2152%
- Gifts$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $3,483 |
| Otsuka America Pharmaceutical, Inc. | 43 | $949 |
| Sunovion Pharmaceuticals Inc. | 64 | $944 |
| Johnson & Johnson | 26 | $710 |
| Neurocrine Biosciences, Inc. | 28 | $651 |
| Lundbeck LLC | 34 | $510 |
| Teva Pharmaceuticals USA, Inc. | 28 | $495 |
| Validus Pharmaceuticals LLC | 12 | $466 |
| Alkermes, Inc. | 24 | $457 |
| Vanda Pharmaceuticals Inc. | 17 | $264 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $123 |
| Indivior Inc. | 5 | $67 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $52 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Rhodes Pharmaceuticals L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$2,711
- Equetro$399
- ABILIFY MAINTENA$343
- ZolpiMist$263
- INGREZZA$243
- INVEGA SUSTENNA$125
- INVEGA TRINZA$125
- SPRAVATO$125
- AUSTEDO$122
- LATUDA$121
How this compares
$9,473 in reported general payments places this provider in the 90th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Greensboro
- Keshavpal ReddyGreensboro$480K
- Gerald PlovskyGreensboro$44K
- Parish McKinneyGreensboro$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
- Robert MilletRaleigh$476K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.